Novo Nordisk Weight-Loss Pill Prescriptions Hit Three Million Since Launch - WSJ

Novo Nordisk Weight-Loss Pill Prescriptions Hit Three Million Since Launch WSJ Novo and Lilly are competing to win the GLP-1 pill market as they prepare for Medicare coverage CNBC ADA: Novo's Wegovy pill reaches new GLP-1 patients with impressive 3M prescription milestone Fierce Pharma 80% of Wegovy Pill Users Never Took a Weight Loss Drug Before. Does This Number Change the Entire Novo Nordisk Bear Case? Yahoo Finance The Wegovy pill is still dominating the GLP-1 pill market MarketWatch